PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 2221065-11 1990 A1 receptors inhibit adenosine 3,5"-cyclic monophosphate (cAMP)-mediated gastrin release via a pertussis toxin-sensitive mechanism, whereas A2 receptors potentiated the response to cAMP-independent stimuli of gastrin release. Cyclic AMP 21-56 gastrin Canis lupus familiaris 73-80 2221065-11 1990 A1 receptors inhibit adenosine 3,5"-cyclic monophosphate (cAMP)-mediated gastrin release via a pertussis toxin-sensitive mechanism, whereas A2 receptors potentiated the response to cAMP-independent stimuli of gastrin release. Cyclic AMP 58-62 gastrin Canis lupus familiaris 73-80 196327-3 1977 Significant increases in antral venous gastrin, caused by gastrin releasers, were associated with a significant rise in cAMP content in the antral mucosa. Cyclic AMP 120-124 gastrin Canis lupus familiaris 39-46 6149697-7 1984 Both epinephrine and dibutyryl cAMP markedly potentiated the release of SLI stimulated by gastrin but were not themselves mutually potentiating. Cyclic AMP 31-35 gastrin Canis lupus familiaris 90-97 6137423-18 1983 Nishizuka et al, recently proposed the novel hypothesis that phosphatidylinositol turnover activated by cAMP-independent agonists will be essentially required to activate protein kinase C. Our results suggest that gastrin can provoke phospholipids turnover including phosphatidylinositol turnover in gastric corporal mucosa. Cyclic AMP 104-108 gastrin Canis lupus familiaris 214-221 91322-8 1979 The mechanisms underlying the potentiating interactions between histamine, carbachol, and gastrin involve step(s) beyond stimulation of cyclic AMP generation. Cyclic AMP 136-146 gastrin Canis lupus familiaris 90-97 6260221-3 1981 The effects of acetylcholine, catecholamines and gastrin on the intracellular content of cyclic AMP and cyclic GMP in antral circular muscle have been determined. Cyclic AMP 89-99 gastrin Canis lupus familiaris 49-56 196327-3 1977 Significant increases in antral venous gastrin, caused by gastrin releasers, were associated with a significant rise in cAMP content in the antral mucosa. Cyclic AMP 120-124 gastrin Canis lupus familiaris 58-65 196327-6 1977 Since the augmented gastrin release was accompanied by an increased mucosal cAMP, the results suggest that cAMP participates in the action of gastrin secretagogues. Cyclic AMP 76-80 gastrin Canis lupus familiaris 20-27 196327-6 1977 Since the augmented gastrin release was accompanied by an increased mucosal cAMP, the results suggest that cAMP participates in the action of gastrin secretagogues. Cyclic AMP 76-80 gastrin Canis lupus familiaris 142-149 196327-6 1977 Since the augmented gastrin release was accompanied by an increased mucosal cAMP, the results suggest that cAMP participates in the action of gastrin secretagogues. Cyclic AMP 107-111 gastrin Canis lupus familiaris 20-27 196327-6 1977 Since the augmented gastrin release was accompanied by an increased mucosal cAMP, the results suggest that cAMP participates in the action of gastrin secretagogues. Cyclic AMP 107-111 gastrin Canis lupus familiaris 142-149 1207241-1 1975 The influence of cyclic AMP on gastrin release from the canine antrum was investigated by a direct in vivo method. Cyclic AMP 17-27 gastrin Canis lupus familiaris 31-38